Genesee Capital Advisors, LLC Abbott Laboratories Transaction History

Genesee Capital Advisors, LLC

$203 Million
Q3 2024

A detailed history of Genesee Capital Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Genesee Capital Advisors, LLC holds 8,575 shares of ABT stock, worth $984,067. This represents 0.48% of its overall portfolio holdings.

Number of Shares

8,575

Previous 8,680 1.21%

Holding current value

$984,067

Previous $901,000 8.44%

% of portfolio

0.48%

Previous 0.45%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$100.07 - $118.13 $10,507 - $12,403	-105 Reduced 1.21%	8,575 $977,000
Q2 2024 Jul 18, 2024	SELL	$100.73 - $112.44 $25,383 - $28,334	-252 Reduced 2.82%	8,680 $901,000
Q1 2024 Apr 22, 2024	SELL	$109.52 - $120.96 $2,080 - $2,298	-19 Reduced 0.21%	8,932 $1.02 Million
Q4 2023 Jan 29, 2024	SELL	$90.19 - $110.4 $453,294 - $554,870	-5,026 Reduced 35.96%	8,951 $985,000
Q3 2023 Oct 24, 2023	SELL	$95.53 - $114.62 $52,828 - $63,384	-553 Reduced 3.81%	13,977 $1.35 Million
Q2 2023 Jul 17, 2023	SELL	$100.78 - $112.29 $27,512 - $30,655	-273 Reduced 1.84%	14,530 $1.58 Million
Q1 2023 Apr 18, 2023	BUY	$96.86 - $114.01 $1,549 - $1,824	16 Added 0.11%	14,803 $1.5 Million
Q4 2022 Jan 20, 2023	SELL	$95.06 - $111.52 $96,961 - $113,750	-1,020 Reduced 6.45%	14,787 $0
Q3 2022 Oct 20, 2022	SELL	$96.76 - $112.03 $25,254 - $29,239	-261 Reduced 1.62%	15,807 $1.53 Million
Q2 2022 Jul 19, 2022	SELL	$102.07 - $123.37 $248,744 - $300,652	-2,437 Reduced 13.17%	16,068 $1.75 Million
Q1 2022 May 25, 2022	SELL	$114.02 - $139.04 $53,931 - $65,765	-473 Reduced 2.49%	18,505 $2.19 Million
Q4 2021 Jan 25, 2022	BUY	$115.53 - $141.46 $24,145 - $29,565	209 Added 1.11%	18,978 $2.67 Million
Q3 2021 Oct 14, 2021	BUY	$116.66 - $129.06 $2.19 Million - $2.42 Million	18,769 New	18,769 $2.22 Million
Q2 2021 Jul 20, 2021	SELL	$105.79 - $124.53 $2.02 Million - $2.38 Million	-19,089 Closed	0 $0
Q1 2021 Apr 16, 2021	SELL	$108.84 - $128.23 $52,460 - $61,806	-482 Reduced 2.46%	19,089 $2.29 Million
Q4 2020 Jan 19, 2021	BUY	$105.0 - $114.42 $29,505 - $32,152	281 Added 1.46%	19,571 $2.14 Million
Q3 2020 Oct 29, 2020	SELL	$91.64 - $111.29 $35,098 - $42,624	-383 Reduced 1.95%	19,290 $2.1 Million
Q2 2020 Jul 20, 2020	SELL	$76.57 - $98.0 $231,011 - $295,666	-3,017 Reduced 13.3%	19,673 $1.8 Million
Q1 2020 Apr 16, 2020	SELL	$62.82 - $91.86 $285,265 - $417,136	-4,541 Reduced 16.68%	22,690 $1.79 Million
Q4 2019 Jan 14, 2020	SELL	$78.51 - $87.4 $32,660 - $36,358	-416 Reduced 1.5%	27,231 $2.37 Million
Q3 2019 Oct 15, 2019	BUY	$81.84 - $88.74 $24,961 - $27,065	305 Added 1.12%	27,647 $2.31 Million
Q2 2019 Jul 19, 2019	SELL	$72.88 - $85.0 $62,968 - $73,440	-864 Reduced 3.06%	27,342 $2.3 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $120,983 - $146,269	1,827 Added 6.93%	28,206 $2.25 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $1.73 Million - $1.96 Million	26,379 New	26,379 $1.91 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Genesee Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Genesee Capital Advisors, LLC with notifications on news.

Account

Genesee Capital Advisors, LLC Abbott Laboratories Transaction History